195 related articles for article (PubMed ID: 4374762)
1. The impact of scientific models on clinical psychopharmacology: an internist's view.
Hollister LE
Semin Psychiatry; 1972 Aug; 4(3):265-9. PubMed ID: 4374762
[No Abstract] [Full Text] [Related]
2. The impact of scientific models on clinical psychopharmacology: a psychiatrist's view.
Cole JO
Semin Psychiatry; 1972 Aug; 4(3):261-4. PubMed ID: 4680224
[No Abstract] [Full Text] [Related]
3. The impact of scientific models on clinical psychopharmacology: a pharmacologist's view.
Lasagna L
Semin Psychiatry; 1972 Aug; 4(3):271-82. PubMed ID: 4680225
[No Abstract] [Full Text] [Related]
4. The impact of scientific models on clinical psychopharmacology: a psychiatrist's view.
Lehmann HE
Semin Psychiatry; 1972 Aug; 4(3):255-9. PubMed ID: 4680223
[No Abstract] [Full Text] [Related]
5. Antipsychotic drug actions: a clue to the neuropathology of schizophrenia?
Matthysse S
Fed Proc; 1973 Feb; 32(2):200-5. PubMed ID: 4348519
[No Abstract] [Full Text] [Related]
6. Toward hypotheses for a biochemical component in the vulnerability to schizophrenia.
Kety SS
Semin Psychiatry; 1972 Aug; 4(3):233-8. PubMed ID: 4155537
[No Abstract] [Full Text] [Related]
7. Alterations of serotonin transmission in schizophrenia.
Abi-Dargham A
Int Rev Neurobiol; 2007; 78():133-64. PubMed ID: 17349860
[TBL] [Abstract][Full Text] [Related]
8. Biochemistry of mental disorders. Report of a WHO Scientific Group.
World Health Organ Tech Rep Ser; 1969; 427():1-40. PubMed ID: 4980629
[No Abstract] [Full Text] [Related]
9. A pharmacological model of the pathophysioloyg of schizophrenia.
Klawans HL; Westheimer R; Goetz CC
Dis Nerv Syst; 1975 May; 36(5):267-75. PubMed ID: 166804
[TBL] [Abstract][Full Text] [Related]
10. Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines.
Snyder SH
Am J Psychiatry; 1973 Jan; 130(1):61-7. PubMed ID: 4345465
[No Abstract] [Full Text] [Related]
11. The dopamine system and the pathophysiology of schizophrenia: a basic science perspective.
Goto Y; Grace AA
Int Rev Neurobiol; 2007; 78():41-68. PubMed ID: 17349857
[TBL] [Abstract][Full Text] [Related]
12. Neurotensin: role in psychiatric and neurological diseases.
Cáceda R; Kinkead B; Nemeroff CB
Peptides; 2006 Oct; 27(10):2385-404. PubMed ID: 16891042
[TBL] [Abstract][Full Text] [Related]
13. Prospects for research on schizophrenia. V. Pharmacological observations, Drug-induced psychoses.
Snyder SH; Aghajanian GK; Matthysse S
Neurosci Res Program Bull; 1972 Nov; 10(4):430-45. PubMed ID: 4663824
[No Abstract] [Full Text] [Related]
14. [Status of and perspectives on psychiatric genomic medicine].
Mors NP; Børglum AD
Ugeskr Laeger; 2005 May; 167(20):2191-3. PubMed ID: 15987082
[No Abstract] [Full Text] [Related]
15. Research still holds the answer.
Kety SK
MH; 1974; 58(1):6-8. PubMed ID: 4359316
[No Abstract] [Full Text] [Related]
16. [The neurovegetative system from the internist's viewpoint].
Hittmair AM
Internist (Berl); 1971 Jul; 12(7):290-9. PubMed ID: 4946380
[No Abstract] [Full Text] [Related]
17. Integrating the neurobiology of schizophrenia. Preface.
Abi-Dargham A; Guillin O
Int Rev Neurobiol; 2007; 78():xiii-xvi. PubMed ID: 17349855
[No Abstract] [Full Text] [Related]
18. [Drugs with an effect on the transmission of stimuli in the peripheral nervous system].
Haller R
Mitt Dtsch Pharm Ges Pharm Ges DDR; 1968 Apr; 38(4):73-84. PubMed ID: 4299580
[No Abstract] [Full Text] [Related]
19. Psychopharmacology in the aged. Use of major psychotropic medications in treatment of the elderly: case examples.
Asnes DP
J Geriatr Psychiatry; 1974; 7(2):189-202. PubMed ID: 4443549
[No Abstract] [Full Text] [Related]
20. Anatomic and molecular principles of psychopharmacology. A primer for psychiatrists.
Heckers S; Konradi C
Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):1-22. PubMed ID: 10674188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
